CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Tiantan Biological Products Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Tiantan Biological Products Corp
No. 2
Shuangqiao Road B, Chaoyang District
Phone: +86 1065439720p:+86 1065439720 BEIJING, BEJ  100024  China Ticker: 600161600161
Business Summary
Beijing Tiantan Biological Products Corp Ltd is a China-based company principally engaged in the research and development, production and sales of blood products. The Company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human immunoglobulin, human rabies immunoglobulin, human hepatitis B immunoglobulin, human histamine immunoglobulin, human prothrombin complex and others. The Company's products are mainly used to treat shock caused by blood loss, trauma and burns, treat primary immunoglobulin G deficiency, neonatal sepsis, infant bronchiolitis, prevent and treat tetanus and others. The Company mainly operates its businesses in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Acting Secretary of the Board HuichuanYang 57 11/28/2024 6/13/2011
Chief Financial Officer HongqingWang 44 11/21/2023 11/21/2023
Chief Compliance Officer, General Counsel XiangCi 46 4/25/2024 3/1/2011
8 additional Officers and Directors records available in full report.

Business Names
Business Name
600161
Beijing Tiantan Biological Product Co.
Beijing Tiantan Biological Products Corp
Chengdu Rongsheng Pharmaceuticals Co. Ltd.

General Information
Number of Employees: 5,298 (As of 12/31/2024)
Outstanding Shares: 1,977,371,446 (As of 3/31/2025)
Shareholders: 72,729
Stock Exchange: SHA
Fax Number: +86 1065436770


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 23, 2025